Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets
- PMID: 17192466
- DOI: 10.2337/db06-0734
Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets
Abstract
Insulin secretion from the 2,000-3,000 beta-cells in an islet is a highly synchronized activity with discharge of insulin in coordinate secretory bursts at approximately 4-min intervals. Insulin secretion progressively declines in type 2 diabetes and following islet transplantation. Both are characterized by the presence of islet amyloid derived from islet amyloid polypeptide (IAPP). In the present studies, we examined the action of extracellular human IAPP (h-IAPP) on morphology and function of human islets. Because oligomers of h-IAPP are known to cause membrane disruption, we questioned if application of h-IAPP oligomers to human islets would lead to disruption of islet architecture (specifically cell-to-cell adherence) and a decrease in coordinate function (e.g., increased entropy of insulin secretion and diminished coordinate secretory bursts). Both hypotheses are affirmed, leading to a novel hypothesis for impaired insulin secretion in type 2 diabetes and following islet transplantation, specifically disrupted cell-to-cell adherence in islets through the actions of membrane-disrupting IAPP oligomers.
Similar articles
-
Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis.Diabetes. 2003 Jul;52(7):1701-8. doi: 10.2337/diabetes.52.7.1701. Diabetes. 2003. PMID: 12829636
-
Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.Diabetes. 1993 Feb;42(2):330-5. doi: 10.2337/diab.42.2.330. Diabetes. 1993. PMID: 8425669
-
Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.J Clin Endocrinol Metab. 2005 Dec;90(12):6678-86. doi: 10.1210/jc.2005-0079. Epub 2005 Oct 4. J Clin Endocrinol Metab. 2005. PMID: 16204373
-
Islet amyloid polypeptide in the islets of Langerhans: friend or foe?Diabetologia. 2000 Jun;43(6):687-95. doi: 10.1007/s001250051364. Diabetologia. 2000. PMID: 10907112 Review.
-
Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?Diabetes. 1991 Mar;40(3):310-4. doi: 10.2337/diab.40.3.310. Diabetes. 1991. PMID: 1999270 Review.
Cited by
-
Probing the binding affinity of amyloids to reduce toxicity of oligomers in diabetes.Bioinformatics. 2015 Jul 15;31(14):2294-302. doi: 10.1093/bioinformatics/btv143. Epub 2015 Mar 15. Bioinformatics. 2015. PMID: 25777526 Free PMC article.
-
Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide.Diabetologia. 2012 Feb 1. doi: 10.1007/s00125-012-2451-2. Online ahead of print. Diabetologia. 2012. PMID: 22301943
-
Short Peptides as Inhibitors of Amyloid Aggregation.Open Biotechnol J. 2011 Dec 23;5:39-46. doi: 10.2174/1874070701105010039. Open Biotechnol J. 2011. PMID: 24653784 Free PMC article.
-
The binary switch that controls the life and death decisions of ER stressed β cells.Curr Opin Cell Biol. 2011 Apr;23(2):207-15. doi: 10.1016/j.ceb.2010.11.005. Epub 2010 Dec 16. Curr Opin Cell Biol. 2011. PMID: 21168319 Free PMC article. Review.
-
Structural similarities and differences between amyloidogenic and non-amyloidogenic islet amyloid polypeptide (IAPP) sequences and implications for the dual physiological and pathological activities of these peptides.PLoS Comput Biol. 2013;9(8):e1003211. doi: 10.1371/journal.pcbi.1003211. Epub 2013 Aug 29. PLoS Comput Biol. 2013. PMID: 24009497 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
